• New Privilege Rule Protects Communications with Foreign Jurisdiction Patent Practitioners From Discovery in PTAB Proceedings.
  • No Reciprocity From Foreign Jurisdiction is Required.

Under a new rule set to take effect on December 7, 2017, communications between patent practitioners authorized to practice patent matters before the United States Patent and Trademark Office (“USPTO”) under 37 C.F.R.

Given the Patent Trial and Appeal Board’s (“PTAB” or “Board”) reluctance to grant motions to amend claims during AIA post-grant proceedings, patent owners faced with post-grant challenges have attempted to circumvent the challenge of amending claims by filing reissue applications of challenged patents.  By doing so, the patent owner attempts to create two parallel proceedings

The Patent Trial and Appeal Board (“PTAB”) enjoys a wide range of discretion on a number of issues.  For instance, the PTAB has interpreted 35 U.S.C. § 314(a) as providing the Director with the discretion to institute or not, regardless of whether there is a reasonable likelihood that the petitioner will prevail on at least

In Perfect Surgical Techniques, Inc. v. Olympus America, Inc., Olympus Medical Systems Corp., IPR2014-00233 (Fed. Cir. Nov. 15, 2016) (Judges Moore, Schall, and O’Malley), the Federal Circuit vacated and remanded the Board’s decision invalidating certain claims of U.S. Patent 6,030,384 (“’384 patent”).  The Board’s decision was based on prior art under pre-AIA §102(a).  This

On Final Written Decision in Pure Fishing, Inc. v. Globeride, Inc., the PTAB determined the Petitioner had failed to establish by a preponderance of the evidence that claims 1 and 2 of U.S. Patent 5,921,489 were unpatentable.  The PTAB’s decision turned on the question of whether two cited references were “analogous to the claimed